MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. Massive losses of -62.07% were the result for the BUY prediction by Stakeholder. Stakeholder has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG ADR | - | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% | 51.689% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% | 67.992% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% | 57.109% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% | 58.872% |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA